Bristol-Myers Squibb
BMY
$44.70
Share price
-8.51%
Change (1 day)
-36.36%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) Fails to deliver data
Key failure to deliver metrics for Bristol-Myers Squibb:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.19 B
- Last 3 months FTD volume: $0.19 B
- Last year FTD volume: $0.29 B
Failures to deliver for Bristol-Myers Squibb (BMY) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013
Volume in USD (price x number of shares), data since 2013Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.19 B | 25.5% |
| 2023 | $0.15 B | -29.53% |
| 2022 | $0.22 B | 107.77% |
| 2021 | $0.10 B | -72.46% |
| 2020 | $0.38 B | -11.25% |
| 2019 | $0.43 B | 203.91% |
| 2018 | $0.14 B | -20.27% |
| 2017 | $0.17 B | 4.53% |
| 2016 | $0.17 B | -7.42% |
| 2015 | $0.18 B | 76.57% |
| 2014 | $0.10 B | 237.33% |
| 2013 | $31.21 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 AbbVie ABBV | $8.76 M | $0.15 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Sanofi SNY | $26.25 M | $54.4 M | 🇫🇷 France |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |